StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ZYME

Zymeworks Inc.

ZYME Nasdaq Pharmaceutical Preparations EDGAR ↗
$23.52
+0.73 +3.20%

Key statistics

from XBRL data in SEC filings
Market cap
$1.72B
Revenue (TTM)
$81.3M
Net income (TTM)
-$103M
EPS (TTM)
$-1.37
P/E ratio
Dividend yield
Free cash flow
-$34.5M
Cash
$244M
Total assets
$478M
Gross margin
52-week range
$11.51 – $29.75

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Regulation FD disclosure Jun 29, 2026 8-K Regulation FD disclosure; Other events May 14, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 8-K Director or officer change Apr 1, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 2, 2026 8-K Results of operations (earnings release); Director or officer change; Other events Jan 12, 2026 8-K Shareholder vote results Dec 30, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Nov 18, 2025 8-K Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2025 8-K Regulation FD disclosure; Other events Sep 2, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Entered a material agreement; Unregistered sale of equity Jun 27, 2025 8-K Regulation FD disclosure; Other events May 30, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 5, 2025 8-K Director or officer change; Other events Feb 18, 2025 8-K Results of operations (earnings release); Other events Jan 8, 2025 8-K Shareholder vote results; Other events Dec 11, 2024 8-K Regulation FD disclosure; Other events Nov 21, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 31, 2024 8-K Director or officer change; Other events Oct 18, 2024 8-K Director or officer change Sep 3, 2024 8-K Entered a material agreement Aug 2, 2024 8-K Regulation FD disclosure; Other events Aug 1, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 1, 2024 8-K Director or officer change Jul 25, 2024 8-K Other events Jun 10, 2024 8-K Other events May 3, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024